PRPO
Price:
$5.9095
Market Cap:
$8.76M
Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; HemeScreen, a suite of robust genetic diagnostic panels; ICE-COLD PCR, a proprietary and patented specimen technology that increases the sensitivity of molecular based tests; and COVID-19 antibody tests. It sells ICE-COLD-PCR technology kits to bio-pharma customers. Precipio, Inc. has collaborations with academic institutions specializing in cancer research, diagnostics, and treatment. ...[Read more]
Industry
Medical - Diagnostics & Research
IPO Date
2017-06-30
Stock Exchange
NASDAQ
Ticker
PRPO
According to Precipio, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -3.26. This represents a change of 206.67% compared to the average of -1.06 of the last 4 quarters.
The mean historical PE Ratio of Precipio, Inc. over the last ten years is -1.39. The current -3.26 PE Ratio has changed 23.40% with respect to the historical average. Over the past ten years (40 quarters), PRPO's PE Ratio was at its highest in in the December 2023 quarter at 2.49. The PE Ratio was at its lowest in in the December 2016 quarter at -13.88.
Average
-1.39
Median
-0.95
Minimum
-3.90
Maximum
-0.02
Discovering the peaks and valleys of Precipio, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.48%
Maximum Annual PE Ratio = -0.02
Minimum Annual Increase = -96.52%
Minimum Annual PE Ratio = -3.90
Year | PE Ratio | Change |
---|---|---|
2023 | -1.44 | 40.30% |
2022 | -1.03 | -73.65% |
2021 | -3.90 | 39.80% |
2020 | -2.79 | 216.34% |
2019 | -0.88 | 315.62% |
2018 | -0.21 | -21.15% |
2017 | -0.27 | 1.48% |
2016 | -0.02 | -84.81% |
2015 | -0.11 | -96.52% |
2014 | -3.22 | 18.25% |
The current PE Ratio of Precipio, Inc. (PRPO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
-2.12
5-year avg
-2.01
10-year avg
-1.39
Precipio, Inc.’s PE Ratio is greater than Biodesix, Inc. (-4.27), greater than Sera Prognostics, Inc. (-6.80), less than Applied DNA Sciences, Inc. (-0.08), greater than Olink Holding AB (publ) (-96.25), greater than CareDx, Inc (-8.52), less than Castle Biosciences, Inc. (136.61), greater than Twist Bioscience Corporation (-11.85), greater than Natera, Inc. (-96.43), less than HTG Molecular Diagnostics, Inc. (-0.02), less than Genetron Holdings Limited (0), less than bioAffinity Technologies, Inc. (-1.79), greater than Psychemedics Corporation (-4.60), greater than Genetic Technologies Limited (-9.57), less than MDxHealth SA (-2.12), less than Star Equity Holdings, Inc. (-1.19), greater than Exagen Inc. (-4.42), less than Burning Rock Biotech Limited (-0.73), less than LumiraDx Limited (-0.01),
Company | PE Ratio | Market cap |
---|---|---|
-4.27 | $186.20M | |
-6.80 | $214.54M | |
-0.08 | $7.82M | |
-96.25 | $3.24B | |
-8.52 | $1.24B | |
136.61 | $834.90M | |
-11.85 | $2.51B | |
-96.43 | $22.08B | |
-0.02 | $1.06M | |
0 | $127.29M | |
-1.79 | $18.88M | |
-4.60 | $13.76M | |
-9.57 | $6.23M | |
-2.12 | $93.05M | |
-1.19 | $9.46M | |
-4.42 | $72.31M | |
-0.73 | $54.55M | |
-0.01 | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Precipio, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Precipio, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Precipio, Inc.'s PE Ratio?
How is the PE Ratio calculated for Precipio, Inc. (PRPO)?
What is the highest PE Ratio for Precipio, Inc. (PRPO)?
What is the 3-year average PE Ratio for Precipio, Inc. (PRPO)?
What is the 5-year average PE Ratio for Precipio, Inc. (PRPO)?
How does the current PE Ratio for Precipio, Inc. (PRPO) compare to its historical average?